Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients.

BMC Endocr Disord · 2012 · PMC3512463 · PMID 23009558

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

Furthermore, significant or borderline significant differences were found in concomitant insulin use with more DET patients treated with Actrapid and more GLAR patients treated with Insuman Rapid.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.